A detailed history of Bleichroeder LP transactions in Dia Medica Therapeutics Inc. stock. As of the latest transaction made, Bleichroeder LP holds 382,317 shares of DMAC stock, worth $1.82 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
382,317
Previous 382,317 -0.0%
Holding current value
$1.82 Million
Previous $1.13 Million 42.06%
% of portfolio
0.54%
Previous 0.41%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$2.16 - $3.66 $345,600 - $585,600
160,000 Added 71.97%
382,317 $1.13 Million
Q3 2023

Nov 09, 2023

SELL
$2.56 - $4.4 $183,808 - $315,920
-71,800 Reduced 24.41%
222,317 $573,000
Q2 2023

Aug 11, 2023

BUY
$1.53 - $4.4 $449,999 - $1.29 Million
294,117 New
294,117 $1.27 Million

Others Institutions Holding DMAC

About DiaMedica Therapeutics Inc.


  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $126M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track This Portfolio

Track Bleichroeder LP Portfolio

Follow Bleichroeder LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleichroeder LP, based on Form 13F filings with the SEC.

News

Stay updated on Bleichroeder LP with notifications on news.